Overview
The Delhi High Court has granted permission to extract and cryopreserve the sperm of an Indian Army soldier in a persistent vegetative state, enabling his wife to pursue IVF treatment. The same week, the Union Budget 2026‑27 unveiled Biopharma SHAKTI, signalling a strategic push to position India as a global hub for biologics.
Key Developments
- Delhi High Court authorises sperm extraction and cryopreservation for a soldier in a vegetative state, upholding reproductive rights and medical ethics.
- Union Budget allocates ₹10,000 crore to the Biopharma SHAKTI programme, creating three new National Institutes for Pharmaceuticals Education and Research (NIPER) and 1,000 accredited clinical‑trial sites.
- January 2026 – Biologics × 3DCC Summit merges biopharma product‑development and 3‑D cell‑culture conferences, highlighting advances in monoclonal antibodies, cell‑ and gene‑therapy platforms.
- Emphasis on production platforms: CHO (Chinese Hamster Ovary) cell lines for glycosylated therapeutics such as anti‑Müllerian hormone (AMH) assays used in IVF.
Important Facts
• Monoclonal antibodies remain the largest segment of biologics, driving demand for advanced cell‑culture facilities.
• Glycosylation – the addition of sugar moieties to proteins – is essential for the activity of many therapeutic proteins; bacter